Hong Zheng
Research Assistant 3 MSCards
About
Research
Publications
2026
Similar androgen receptor expression in male and female AML
Prabhu K, Qian F, Sarkar D, Zheng H, Paulson R. Similar androgen receptor expression in male and female AML. Blood Advances 2026, 10: 4108. PMID: 41921074, PMCID: PMC13261862, DOI: 10.1182/bloodadvances.2026020008.Commentaries, Editorials and LettersMolecular Flexibility and Electrostatic Interactions Drive the Nanoscale Structure of Coiled-Coil GM130 Protein Condensates
Mateos-Gil P, Feito A, Cava D, Tejedor A, Almendro-Vedia V, Coleman J, Zheng H, Simanjuntak M, Goder J, Rothman J, Espinosa J, Pincet F, López-Montero I. Molecular Flexibility and Electrostatic Interactions Drive the Nanoscale Structure of Coiled-Coil GM130 Protein Condensates. PRX Life 2026, 4: 023021. DOI: 10.1103/lp87-svtc.Peer-Reviewed Original ResearchPharmacological blockade of rho kinase enhances venetoclax responses in translational models of acute myeloid leukemia.
Golla U, Bhalodia R, Annageldiyev C, Patel S, Bollu V, Tan S, Cabot M, Feith D, Loughran T, Levine R, Mineishi S, Zheng H, Minagawa K, Hengst J, Sholler G, Desai D, Dovat S, Fisher-Wellman K, Claxton D, Sharma A. Pharmacological blockade of rho kinase enhances venetoclax responses in translational models of acute myeloid leukemia. Haematologica 2026 PMID: 41924919, DOI: 10.3324/haematol.2025.289041.Peer-Reviewed Original ResearchSurvival after intensive therapy or clofarabine in fit older adults with acute myeloid leukemia: E2906 phase 3 trial
Foran J, Sun Z, Luger S, Claxton D, Lazarus H, Arber D, Rowe J, Paietta E, Racevskis J, Garrett-Bakelman F, Zhang Y, Altman J, Al-Kali A, Zheng H, Pratz K, Broun E, Powell B, O’Dwyer K, Godwin J, Ofran Y, Litzow M, Tallman M. Survival after intensive therapy or clofarabine in fit older adults with acute myeloid leukemia: E2906 phase 3 trial. Blood Neoplasia 2026, 3: 100194. PMID: 41890705, PMCID: PMC13014643, DOI: 10.1016/j.bneo.2026.100194.Peer-Reviewed Original Research
2025
Androgen receptor signaling as a new target for intervention in acute myeloid leukemia
Qian F, Sarkar D, Arner B, Peduzzi V, Bai Y, Ruan B, Jia B, Zheng H, Paulson R, Prabhu K. Androgen receptor signaling as a new target for intervention in acute myeloid leukemia. Blood Advances 2025, 9: 6326-6339. PMID: 40991369, PMCID: PMC12744263, DOI: 10.1182/bloodadvances.2024012639.Peer-Reviewed Original ResearchEngineered suppressor T cells overexpressing IFN-α and PD-L1 inhibit GVHD but retain GVL effects in mice
Tian Y, Jia B, Lee C, Huang Q, Zhao C, Abraham C, Mo W, Zhang Y, Chen M, Wang Y, Blazar B, Zheng H, Zhang Y. Engineered suppressor T cells overexpressing IFN-α and PD-L1 inhibit GVHD but retain GVL effects in mice. Molecular Therapy 2025, 34: 898-915. PMID: 41234014, PMCID: PMC12882687, DOI: 10.1016/j.ymthe.2025.11.019.Peer-Reviewed Original ResearchSafety and feasibility of intermediate-dose post-transplant cyclophosphamide for graft-versus-host disease prophylaxis
Venugopal N, McGowan A, Inoue Y, Zheng H, Cioccio J, Rakszawski K, Songdej N, Nickolich M, Naik S, Ehmann C, Sivik J, Mierski J, Silar B, Vajdic C, Shike H, Mineishi S, Minagawa K. Safety and feasibility of intermediate-dose post-transplant cyclophosphamide for graft-versus-host disease prophylaxis. Annals Of Hematology 2025, 104: 6451-6462. PMID: 41081866, PMCID: PMC12764680, DOI: 10.1007/s00277-025-06657-8.Peer-Reviewed Original ResearchPrior status of graft‐versus‐host disease affects donor lymphocyte infusion outcomes in patients with relapsed haematological malignancies after allogeneic stem cell transplantation
Velasco C, Inoue Y, Cioccio J, Rakszawski K, Songdej N, Nickolich M, Zheng H, Naik S, Ehmann C, Mierski J, Silar B, Vajdic C, Greiner R, Brown V, Mineishi S, Shike H, Minagawa K. Prior status of graft‐versus‐host disease affects donor lymphocyte infusion outcomes in patients with relapsed haematological malignancies after allogeneic stem cell transplantation. British Journal Of Haematology 2025, 207: 515-524. PMID: 40534233, PMCID: PMC12378914, DOI: 10.1111/bjh.20215.Peer-Reviewed Original ResearchCytotoxic lymphocytes induced by engineered human dendritic cells mediate potent anti-leukemia activity
Zhao C, Jia B, Jiang Y, Shike H, Annageldiyev C, Cioccio J, Minagawa K, Mineishi S, Ehmann W, Schell T, Cheng H, Zheng H. Cytotoxic lymphocytes induced by engineered human dendritic cells mediate potent anti-leukemia activity. Cancer Immunology, Immunotherapy 2025, 74: 117. PMID: 39998689, PMCID: PMC11861774, DOI: 10.1007/s00262-025-03971-y.Peer-Reviewed Original Research
2024
Sensitivity and Specificity of Chimerism Tests in Predicting Leukemia Relapse Using Increasing Mixed Chimerism
Zhang R, Shang Y, Cioccio J, Rakszawski K, Nickolich M, Ehmann C, Inoue Y, Naik S, Rybka W, Zheng H, Mierski J, Silar B, Liao J, Greiner R, Brown V, Claxton D, Ning J, Zhou S, Mineishi S, Minagawa K, Shike H. Sensitivity and Specificity of Chimerism Tests in Predicting Leukemia Relapse Using Increasing Mixed Chimerism. Journal Of Molecular Diagnostics 2024, 26: 1159-1170. PMID: 39603755, DOI: 10.1016/j.jmoldx.2024.09.003.Peer-Reviewed Original Research
Get In Touch
Contacts
Email